Poly Medicure Ltd Share Price

Q: What is the share price of Poly Medicure Ltd today?

Poly Medicure Ltd share price as on 18 Jan 2025 is ₹2509

Medical Equipment

NSE: POLYMED Small Cap ISIN: INE205C01021

As on 18 January 2025 at 07:40 IST

₹2,509

+ 29.20

(1.18%)

Sell Buy

About Poly Medicure Ltd

Poly Medicure Ltd (POLYMED) is a leading Indian company specializing in the manufacturing and sale of medical devices. The company is dedicated to providing high-quality healthcare solutions. Operating in the healthcare sector, Polymed was incorporated on March 30, 1995, making it many years old. Its headquarters is located in the city of New Delhi, India. The company’s main products encompass a wide range of medical devices, including IV cannulas, catheters, and dialysis products. These offerings are designed to meet the needs of various medical specialities and are used in hospitals. Read More...

Over 1 Month

-9.76%

Over 6 Months

18.93%

Over 1 Year

72.61%

Over 3 Years

175.91%

Poly Medicure Ltd Summary

Close ₹ 2,509

Open ₹ 2,464

High ₹ 2,540

Low ₹ 2,464

Volume 1,87,505

Net Turnover (in ₹) ₹ 47,02,52,633.50

52Wk High ₹ 3,357.80

52Wk Low ₹ 1,361

52Wk High / Low

1,361

3,357.80

Poly Medicure Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 25,422.62

EPS (TTM) 28.77

Book Value (BV) 254.10

Div. Yield 0.11 %

P/E (TTM) 87.31

Price/Book Value 9.89

Delivery % 74.42 %

Face Value 5

Key Ratios

PE Ratio 60.57

PB Ratio 10.46

EV to Sales 11.69

PEG Ratio 1.49

ROA 15.44

ROE 18.70

Debt-Equity 0.11

Net Profit Margin 19.26

Operating Profit Margin 31.35

Poly Medicure Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	1,434.54	1,151.42	960.97	804.88	705.70
Total Expenses	1,092.80	915.85	768.17	628.14	582.12
Profit Before Tax	344.27	237.49	195.24	180.05	125.72
Profit After Tax	258.26	179.28	146.51	135.87	95.88
Operating Profit after Depreciation	353.04	244.40	197.05	185.26	141.90

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	875.81	639.92	490.49	427.68	367.50
Total Non Current Assets	1,017.05	770.52	593.40	519.62	449.54
Total Current Assets	841.63	806.69	783.44	704.11	317.79
TOTAL ASSETS	1,858.67	1,577.21	1,376.83	1,223.73	767.32
Total Shareholder's Fund	1,470.05	1,241.63	1,087.48	965.57	434.82

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	266.08	191.05	123.47	118.73	128.30
Net Cash used in Investing Activities	-240.94	-179.24	-85.33	-435.58	-107.26
Net Cash used in Financing Activities	-20.15	-12.51	-35.34	316.95	-20.51

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	1,365.43	1,104.33	918.09	766.67	664.75
Total Expenses	1,030.53	867.51	723.37	593.29	542.96
Profit Before Tax	334.89	236.83	194.72	173.38	121.78
Profit After Tax	251.72	179.04	146.02	129.51	92.38
Operating Profit after Depreciation	345.63	245.13	198.32	181.29	139.44

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	834.86	602.64	453.32	391.40	332.05
Total Non Current Assets	1,029.57	782.49	592.97	513.73	446.65
Total Current Assets	791.78	755.27	740.99	673.68	293.31
TOTAL ASSETS	1,821.35	1,537.76	1,333.96	1,187.41	739.95
Total Shareholder's Fund	1,458.25	1,234.12	1,076.97	954.01	429.28

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	256.10	196.83	126.26	116.40	126.91
Net Cash used in Investing Activities	-237.02	-189.18	-88.71	-434.41	-105.67
Net Cash used in Financing Activities	-17.32	-7.89	-39.71	318.92	-22.25

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	420.02	384.78	378.07	339.60	337.29
Total Expenses	304.69	280.86	281.49	249.38	253.07
Profit Before Tax	117.99	98.46	92.46	87.82	80.94
Profit After Tax	87.45	74.04	68.36	65.02	62.19
Operating Profit after Depreciation	142.18	121.27	111.78	107.50	99.15

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	402.47	367.42	360.93	320.86	319.90
Total Expenses	289.54	266.22	263.52	236.46	237.29
Profit Before Tax	116.93	96.07	93.98	82.08	77.96
Profit After Tax	87.22	72.30	70.53	61.46	59.21
Operating Profit after Depreciation	140.17	118.03	113.07	100.96	95.39

Poly Medicure Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 2,450.27

S2 2,420.73

S3 2,395.37

Pivot 2,475.63

R1 2,505.17

R2 2,530.53

R3 2,560.07

Moving Average

20 SMA 2,625.23

50 SMA 2,717.32

100 SMA 2,596.62

200 SMA 2,218.61

Poly Medicure Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

Poly Medicure Ltd

₹3/Share

Announcement Date 19 Sep 2024

Record Date 20 Sep 2024

Div Yield 60%

AGM Date: 26 Sep 2022

AGM 26/09/2022 Pursuant to Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the 'SEBI Listing Regulations') read with the General Circular No. 2/2022 dated 5th May, 2022 issued by the Ministry of Corporate Affairs. We herewith enclosed the newspaper advertisement-published on 4th September, 2022 in Financial Express, English All Edition and Jansatta, Hindi Delhi Edition. (As Per BSE Announcement dated on 05.09.2022) Pursuant to provisions of Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we wish to submit summary of proceedings of the 27th Annual General Meeting of the Company held on 26th September, 2022, through Video Conferencing ('VC')/Other Audio Visual Means ('OAVM'). Further, the detailed results of remote e-voting and the e-voting conducted at the time of AGM on all the businesses as set out in the Notice, as required under Regulation 44 of the SEBI Listing Regulations shall be forwarded to you on the receipt of Scrutinizer''s Report. (As Per BSE Announcement Dated on 26.09.2022) Voting results of the 27th Annual General Meeting pursuant to Regulation 44(3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 along with Scrutinizer's Report. Pursuant to regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the details of voting results in the prescribed format of the items/businesses transacted at the 27th Annual General Meeting of the Company held on Monday, 26th day of September, 2022 at 10.00 a.m. through Video Conferencing (VC) / Other Audio Visual Means (OAVM). (As per BSE Announcement Dated on 28/9/2022)

AGM Date: 28 Sep 2023

AGM 28/09/2023 Pursuant to provisions of Regulation 30 read with para A of part A of Schedule III of SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations'), we wish to submit summary of proceedings of the 28th Annual General Meeting of the Company held on 28th September, 2023, through video conferencing ('VC') / Other Audio Visual Means ('OAVM'). (As Per BSE Announcement dated on 28.09.2023)

AGM Date: 26 Sep 2024

AGM 26/09/2024 Dear Sir/Ma''am, With reference to the captioned subject, we are submitting herewith the Notice of Annual General Meeting (''AGM'') along with the Annual Report for the Financial Year 2023-2024, which is being sent to the shareholders by Electronic Mode. The 29TH Annual General Meeting of the Company will be held on THURSDAY, the 26th September, 2024 at 10:00 A.M. (IST) through Video Conferencing/Other Audio Visual means (As Per BSE Announcement Dated on: The Company informed the Exchange about the voting results and scrutinizers report for the Annual General Meeting held on 26th September, 2024. (As per BSE Announcement Dated on 28/09/2024)

Poly Medicure Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Poly Medicure Ltd	₹2,511.90	₹25,452.01
Max Healthcare Institute Ltd	₹1,029.65	₹1,00,095.58
Apollo Hospitals Enterprise Ltd	₹6,826.65	₹98,156.75
Fortis Healthcare Ltd	₹644.60	₹48,664.60
Syngene International Ltd	₹819.55	₹32,989.92
Global Health Ltd	₹1,020.20	₹27,401.28

Poly Medicure Ltd News

Poly Medicure enters into JV agreement with AMPIN C&I Power

To set up solar power project for captive consumption

10 Jan 2025, 07:23 pm

Poly Medicure Ltd leads losers in 'A' group

Adani Green Energy Ltd, DCM Shriram Ltd, Fortis Healthcare Ltd and Emami Ltd are among the other losers in the BSE's 'A' group today, 26 November 2024.

26 Nov 2024, 03:00 pm

Poly Medicure Ltd leads losers in 'A' group

Voltamp Transformers Ltd, Force Motors Ltd, Vodafone Idea Ltd and PVR Inox Ltd are among the other losers in the BSE's 'A' group today, 04 November 2024.

04 Nov 2024, 03:00 pm

Poly Medicure corrects on profit selling

Poly Medicure dropped 7.07% to Rs 2939, following a sharp rally in the past three sessions.

04 Nov 2024, 02:00 pm

Poly Medicure to announce Quarterly Result

On 28 October 2024

24 Oct 2024, 06:22 pm

Poly Medicure Ltd Stock Analysis

Annual revenue for Poly Medicure Ltd increased by 23.64% to ₹1,365.43 crore in FY 2024 from ₹1,104.33 crore in FY 2023.
Annual Net Profit for Poly Medicure Ltd increased by 40.59% to ₹251.72 crore in FY 2024 from ₹179.04 crore in FY 2023.
Promoter Shareholding in Poly Medicure Ltd decreased by 0.19% in the most recent quarter, from 62.56% in September 2024 to 62.44% in December 2024.
Poly Medicure Ltd delivered a 1-year return of 72.61% compared to the Nifty 50, which provided a return of 7.56% as of the last trading session.
Poly Medicure Ltd share price moved up by 1.18% from its previous close of INR ₹2,479.80. The latest Poly Medicure Ltd share price is INR ₹2,509.
Poly Medicure Ltd share price today has been at a low of 2,464 and a high of 2,540. Over the past 52 weeks, the Poly Medicure Ltd share price has seen a low of 1,361 and a high of 3,357.80.

About Poly Medicure Ltd

Poly Medicure Ltd is a leading Indian company specializing in the manufacturing and sale of medical devices. The company is dedicated to providing high-quality healthcare solutions. It has a diverse product portfolio that includes infusion therapy and dialysis products.

Poly Medicure Ltd operates in the healthcare sector. It specializes in the medical equipment and supplies industry. The company was incorporated on March 30, 1995. Its headquarters is located in New Delhi, India.

The promoters of the company include Ezekiel Global Business Solutions LLP, with a 12.20% stake. The company has managerial promoters who manage the operations of the company. They are -

Devendra Raj Mehta
Himanshu Baid
Rishi Baid
Jugal Kishore Baid
Mukulika Baid

Poly Medicure Ltd offers a wide range of medical devices. Its main products include IV cannulas, blood bags, catheters, endotracheal tubes, and dialysis products. These products are tailored to meet the needs of various medical specialities. They are used in hospitals and healthcare facilities around the world.

As of the latest data, Poly Medicure Ltd is not the number one stock in its sector, but it is a significant player with a strong market presence. The company has a market capitalization of approximately ₹27,680 crore as of 2024.

The registered office, as well as the office of the registrars of Poly Medicure Ltd, is in Okhla Industrial Estate, New Delhi. Poly Medicure Ltd continues to innovate and expand its product range. It maintains a strong focus on quality and customer satisfaction. The company has a strong portfolio and a commitment to excellence. This positions it well for continued growth in the healthcare industry.

The vision of Poly Medicure Limited

Poly Medicure Ltd, often known as Polymed, is a company driven by a clear and compelling vision. This vision centres on providing the highest quality healthcare to people around the world. The company believes that access to quality healthcare is a fundamental right, and it strives to make this a reality through its innovative products and services.

The vision of Poly Medicure Ltd is rooted in a deep commitment to excellence. The company strives to be a global leader in the medical devices industry. It focuses on delivering products that meet the highest standards of quality and safety. This commitment is evident in every aspect of the company's operations. It spans research and development, manufacturing, and customer service.

Innovation is at the heart of Poly Medicure Ltd's vision. The company invests significantly in research and development. It focuses on creating cutting-edge medical devices that enhance patient outcomes. This focus on innovation keeps Polymed at the forefront of the medical devices industry. The company continually introduces new products that meet the evolving needs of healthcare providers and patients.

Sustainability is another key component of Poly Medicure Ltd's vision. The company understands the importance of environmental stewardship. It is dedicated to minimizing its environmental impact. This commitment is reflected in the company's efforts to reduce waste and promote sustainable practices across its operations. Polymed's sustainability initiatives aim to ensure the company can continue providing high-quality healthcare products. At the same time, they focus on protecting the planet for future generations.

Poly Medicure Ltd's vision also emphasizes the importance of customer satisfaction. The company strives to exceed customer expectations by delivering high-quality products. These products are also reliable and easy to use. This customer-centric approach has helped Polymed build strong relationships with healthcare providers and patients around the world.

The company's vision extends beyond its products and services to include its corporate culture. Poly Medicure Ltd is committed to fostering a positive and inclusive work environment where employees are encouraged to innovate and excel. The company believes that a motivated and engaged workforce is key to achieving its vision. This vision is to provide the highest quality healthcare.

Poly Medicure Ltd's vision is also reflected in its commitment to social responsibility. The company is dedicated to making a positive impact on the communities it serves. This commitment is demonstrated through various corporate social responsibility initiatives. These include efforts to improve access to healthcare in underserved areas and support for educational and community development programs.

The vision of Poly Medicure Ltd is not just about what the company does but also how it does it. The company is committed to conducting its business with integrity and transparency. This commitment to ethical business practices is a cornerstone of Polymed's vision and is essential to building trust with customers and stakeholders.

Poly Medicure Ltd's vision is ambitious, and it is well-positioned to achieve it. With a strong foundation of innovation and social responsibility, Polymed is poised to continue its growth and make a lasting impact on the healthcare industry. The company's vision serves as a guiding light. It inspires employees to strive for excellence and make a difference in the lives of people around the world.